EP.12A.09 Oligoprogression and Osimertinib Continuation Post-progression in Patients with EGFR-Mutations

Autor: Mai, V., Lee, J., Zhan, L., Brown, M.C., Balaratnam, K., Khan, K., Cheng, S., Barghout, S., Al-Agha, F., Raptis, R., Kuang, K., Eng, L., Sacher, A.G., Bradbury, P.A., Leighl, N.B., Cabanero, M., Hsu, R., Pal, P., Tsao, M.S., Shepherd, F.A., Xu, W., Liu, G.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S622-S622
Databáze: ScienceDirect